23 March 2011
The early diagnosis of acute renal graft dysfunction: A challenge we face. The role of novel biomarkers
Ahmed HalawaAnn Transplant 2011; 16(1): 90-98 :: ID: 881646
Abstract
ABSTRACT: Acute graft dysfunction can be caused by ischaemic damage or immunological injury leading to serious consequences both in the short and long term. We are in a desperate need for biomarkers of immune and nonimmune injury at different time points of the transplantation time course, beginning from a potential kidney donors where acute kidney damage can pass unnoticed, during the early post-transplant periods to predict acute transplant dysfunction due to various causes and during long term follow up to predict chronic histological changes. The implementation of these novel biomarkers could increase the sensitivity of diagnosis and monitoring of kidney injury in kidney transplant recipients. Traditionally acute graft dysfunction is diagnosed by measuring serum creatinine concentrations. Unfortunately rise in serum creatinine is a late sign of kidney damage. It indicates rather predicts the damage. The treatment, in order to be effective, must be instituted very early after the initiating insult, well before the serum creatinine even begins to rise. Fortunately, emerging technologies such as functional genomics and proteomics have uncovered novel candidates that are emerging as potentially useful biomarkers of acute kidney injury (AKI). The most promising of biomarkers in AKI for clinical use include a plasma panel consisting of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin C and a urine panel including NGAL, Il-18 and Kidney Injury Molecule 1 (KIM-1). Most of these biomarkers were developed in non-transplant AKI, yet their role in clinical transplantation has to be identified.
Keywords: NGAL, cystatin C, IL18, Kim 1, reperfusion/reperfusion injury , Kidney Transplantation
SARS-CoV-2/COVID-19
17 June 2022 : Case report
Extrapulmonary Manifestations of SARS-CoV-2: A Report of 3 Cases and a Literature ReviewAnn Transplant In Press; DOI: 10.12659/AOT.935874
12 April 2022 : Letter/Correspondence
Pancreas Allograft Thrombosis as a Post-COVID-19 Complication in a Diabetic Patient After Pancreas Transpla...Ann Transplant 2022; 27:e935863
12 November 2021 : Original article
Coronavirus Disease 2019 (COVID-19) in Solid Organ Transplant Recipients: A Case-Control StudyAnn Transplant 2021; 26:e933152
26 October 2021 : Original article
Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 PandemicAnn Transplant 2021; 26:e933001
In Press
23 Jun 2022 : Original article
Evaluation of Deceased Donor Kidney Transplantation in the Eurotransplant Senior Program in Comparison to S...Ann Transplant In Press; DOI: 10.12659/AOT.936514
21 Jun 2022 : Case report
Extrapulmonary Manifestations of SARS-CoV-2: A Report of 3 Cases and a Literature ReviewAnn Transplant In Press; DOI: 10.12659/AOT.935874
20 Jun 2022 : Original article
The Association Between Tacrolimus Levels and Hyperkalemia in Allograft Recipients Who Underwent Heart or L...Ann Transplant In Press; DOI: 10.12659/AOT.935607
15 Jun 2022 : Original article
Donor CYP3A5 Expression Decreases Renal Transplantation Outcomes in White Renal Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.936276
Most Viewed Current Articles
26 Jan 2022 : Review article
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive ModelsDOI :10.12659/AOT.934924
Ann Transplant 2022; 27:e934924
29 Dec 2021 : Original article
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
24 Jul 2020 : Review article
Kidney Transplantation in the Times of COVID-19 – A Literature ReviewDOI :10.12659/AOT.925755
Ann Transplant 2020; 25:e925755
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860